SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form F-1 - Registration statement for certain foreign private issuers:
SEC Accession No. 0001213900-23-049716
Filing Date
2023-06-16
Accepted
2023-06-16 17:01:14
Documents
5

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea180305-f1_altamiratherap.htm F-1 424509
2 AMENDMENT NO. 1 TO LOAN AGREEMENT, BETWEEN ALTAMIRA THERAPEUTICS LTD. AND THE LE ea180305ex10-41_altamirathe.htm EX-10.41 11655
3 CONSENT OF DELOITTE AG ea180305ex23-1_altamirathe.htm EX-23.1 2718
4 FILING FEE TABLE ea180305ex-fee_altamirathe.htm EX-FILING FEES 46473
5 GRAPHIC image_001.jpg GRAPHIC 9729
  Complete submission text file 0001213900-23-049716.txt   500202
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000
Business Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON HM 11 D0 00000 41 (0) 41 729 71 94
Altamira Therapeutics Ltd. (Filer) CIK: 0001601936 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: F-1 | Act: 33 | File No.: 333-272741 | Film No.: 231022104
SIC: 2834 Pharmaceutical Preparations